Pfizer will present data from more than 60 abstracts at ASCO 2025, including 15 oral presentations highlighting advancements across breast, genitourinary, hematologic, thoracic, and colorectal cancers.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.